Cesarean or Vaginal Delivery for Preterm Fetal Growth Restriction?
BACKGROUND AND PURPOSE:
The reasoning behind performing scheduled sections for preterm infants with growth restriction is the concern that the fetus will not tolerate labor
Baalbaki et al. (American Journal of Perinatology, 2017) compared neonatal outcomes in preterm FGR following induction of labor vs planned cesarean section
Retrospective cohort study (2011-2014)
Cohort: Indicated preterm births with prenatally diagnosed FGR (defined as EFW <10th percentile)
Exclusion criteria: Delivery <23 weeks or >34 weeks; fetal anomalies; spontaneous labor, maternal cardiac disease or HIV, lack of intrapartum fetal monitoring or IUFD
Patients were classified based on intended mode of delivery
Choice was based on physician’s judgement
Cesarean section for obstetric indications such as malposition and nonreassuring fetal status
Cesarean not usually based on abnormal umbilical artery Dopplers alone
Primary outcome was a composite of adverse neonatal outcomes, including perinatal death, cord blood acidemia, chest compressions during neonatal resuscitation, seizures, culture-proven sepsis, necrotizing enterocolitis, and grade III–IV intraventricular hemorrhage
Secondary analysis was performed examining the impact of umbilical artery Dopplers
The study included 101 fetuses with growth restriction between 23 and 34 weeks
75 underwent planned C-section
46.2% of inductions resulted in vaginal deliveries
Cesarean section was associated with earlier gestational age, lower EFW and abnormal Dopplers
Nonreassuring fetal status was the primary indication for cesarean section
Scheduled cesarean was not associated with a decreased risk of the composite outcome after adjusting for gestational age and antenatal steroids
Adjusted odds ratio [aOR] 1.61 (95% CI, 0.45–5.78)
This remained true even when only those with abnormal umbilical artery Dopplers (absent or reversed flow) were considered
aOR, 2.8 (95% CI, 0.40–20.2)
Only 20% with abnormal/critical Dopplers delivered vaginally
Authors recognize limitations of study including small sample size; however, the study strengths included detailed patient-level data
Planned cesarean section was not associated with decreased risk of neonate morbidity, even when considering critical umbilical artery Dopplers
Results suggest that cesarean should not be considered a contraindication to induction of labor in the setting of preterm FGR, even in the setting of critical Dopplers
Future studies should be conducted to validate the findings in this paper
Please log in to access ObGFirst and the 2T US Atlas
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan